comparemela.com
Home
Live Updates
Deborahj Wong - Breaking News
Pages:
Latest Breaking News On - Deborahj wong - Page 1 : comparemela.com
Dr Wong on Atezolizumab After Definitive Local Therapy in High-Risk HNSCC
Deborah J. Wong, MD, PhD, discusses the evaluation of atezolizumab vs placebo after definitive local therapy in high-risk, locally advanced HNSCC.
Los angeles
United states
Deborahj wong
University of california
Los angeles school of medicine
Los angeles school
Atezolizumab Fails to Improve Survival Outcomes After Definitive Local Therapy in High-Risk HNSCC
Administration of atezolizumab after definitive local therapy did not improve EFS or OS in patients with head and neck squamous cell carcinoma.
United states
Deborahj wong
California los angeles school
Middle east
North america
Head amp neck cancers
Atezolizumab after definitive local therapy
Event free survival or overall in patients with head and neck squamous cell carcinoma
2024 aacr annual meeting
vimarsana © 2020. All Rights Reserved.